nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—Cetirizine—allergic rhinitis	0.451	1	CrCtD
Loperamide—Haloperidol—Cetirizine—allergic rhinitis	0.0391	0.13	CrCrCtD
Loperamide—Clemastine—Cetirizine—allergic rhinitis	0.0298	0.0995	CrCrCtD
Loperamide—Fexofenadine—Cetirizine—allergic rhinitis	0.0282	0.0942	CrCrCtD
Loperamide—Anileridine—Cetirizine—allergic rhinitis	0.0268	0.0895	CrCrCtD
Loperamide—Buclizine—Cetirizine—allergic rhinitis	0.0268	0.0895	CrCrCtD
Loperamide—Meclizine—Cetirizine—allergic rhinitis	0.0244	0.0814	CrCrCtD
Loperamide—Cloperastine—Dimenhydrinate—allergic rhinitis	0.017	0.0567	CrCrCtD
Loperamide—Cloperastine—Cetirizine—allergic rhinitis	0.0154	0.0514	CrCrCtD
Loperamide—CYP2B6—Diphenhydramine—allergic rhinitis	0.0151	0.0889	CbGbCtD
Loperamide—Toremifene—Diphenhydramine—allergic rhinitis	0.0148	0.0493	CrCrCtD
Loperamide—ABCB1—Desloratadine—allergic rhinitis	0.0134	0.0794	CbGbCtD
Loperamide—CYP2D6—Desloratadine—allergic rhinitis	0.0127	0.0748	CbGbCtD
Loperamide—Isopropamide—Diphenhydramine—allergic rhinitis	0.0117	0.0392	CrCrCtD
Loperamide—CYP2C8—Loratadine—allergic rhinitis	0.0114	0.0673	CbGbCtD
Loperamide—CYP2C8—Montelukast—allergic rhinitis	0.0114	0.0673	CbGbCtD
Loperamide—Tamoxifen—Diphenhydramine—allergic rhinitis	0.0102	0.0339	CrCrCtD
Loperamide—Methadyl Acetate—Diphenhydramine—allergic rhinitis	0.00982	0.0328	CrCrCtD
Loperamide—Levomethadyl Acetate—Diphenhydramine—allergic rhinitis	0.00982	0.0328	CrCrCtD
Loperamide—Dextropropoxyphene—Diphenhydramine—allergic rhinitis	0.00806	0.0269	CrCrCtD
Loperamide—Cloperastine—Diphenhydramine—allergic rhinitis	0.00806	0.0269	CrCrCtD
Loperamide—CYP3A4—Flunisolide—allergic rhinitis	0.00806	0.0476	CbGbCtD
Loperamide—ABCB1—Loratadine—allergic rhinitis	0.00772	0.0456	CbGbCtD
Loperamide—CYP3A4—Olopatadine—allergic rhinitis	0.00757	0.0447	CbGbCtD
Loperamide—CYP2D6—Loratadine—allergic rhinitis	0.00728	0.043	CbGbCtD
Loperamide—CYP2D6—Diphenhydramine—allergic rhinitis	0.00728	0.043	CbGbCtD
Loperamide—Fentanyl—Diphenhydramine—allergic rhinitis	0.00718	0.0239	CrCrCtD
Loperamide—ABCB1—Methylprednisolone—allergic rhinitis	0.00706	0.0417	CbGbCtD
Loperamide—Methadone—Diphenhydramine—allergic rhinitis	0.00675	0.0225	CrCrCtD
Loperamide—CYP2C8—Hydrocortisone—allergic rhinitis	0.00635	0.0375	CbGbCtD
Loperamide—Clofedanol—Diphenhydramine—allergic rhinitis	0.00583	0.0194	CrCrCtD
Loperamide—CYP2B6—Dexamethasone—allergic rhinitis	0.00521	0.0308	CbGbCtD
Loperamide—POMC—autonomic nervous system—allergic rhinitis	0.00499	0.254	CbGeAlD
Loperamide—CYP3A4—Loratadine—allergic rhinitis	0.00463	0.0273	CbGbCtD
Loperamide—CYP3A4—Montelukast—allergic rhinitis	0.00463	0.0273	CbGbCtD
Loperamide—ABCB1—Betamethasone—allergic rhinitis	0.00459	0.0271	CbGbCtD
Loperamide—ABCB1—Prednisolone—allergic rhinitis	0.00453	0.0267	CbGbCtD
Loperamide—ABCB1—Hydrocortisone—allergic rhinitis	0.0043	0.0254	CbGbCtD
Loperamide—CYP3A4—Methylprednisolone—allergic rhinitis	0.00423	0.025	CbGbCtD
Loperamide—CYP2C8—Dexamethasone—allergic rhinitis	0.00395	0.0233	CbGbCtD
Loperamide—CYP3A4—Triamcinolone—allergic rhinitis	0.00321	0.0189	CbGbCtD
Loperamide—CYP3A4—Betamethasone—allergic rhinitis	0.00275	0.0162	CbGbCtD
Loperamide—CYP3A4—Prednisolone—allergic rhinitis	0.00271	0.016	CbGbCtD
Loperamide—ABCB1—Dexamethasone—allergic rhinitis	0.00267	0.0158	CbGbCtD
Loperamide—CYP3A4—Hydrocortisone—allergic rhinitis	0.00257	0.0152	CbGbCtD
Loperamide—CYP2D6—Dexamethasone—allergic rhinitis	0.00252	0.0149	CbGbCtD
Loperamide—CYP3A4—Dexamethasone—allergic rhinitis	0.0016	0.00945	CbGbCtD
Loperamide—CALM1—autonomic nervous system—allergic rhinitis	0.00136	0.069	CbGeAlD
Loperamide—POMC—respiratory system—allergic rhinitis	0.00128	0.0653	CbGeAlD
Loperamide—CALM2—ear—allergic rhinitis	0.00122	0.062	CbGeAlD
Loperamide—CALM1—ear—allergic rhinitis	0.00121	0.0617	CbGeAlD
Loperamide—POMC—skin of body—allergic rhinitis	0.00102	0.0519	CbGeAlD
Loperamide—POMC—lung—allergic rhinitis	0.000682	0.0347	CbGeAlD
Loperamide—CALM2—exocrine gland—allergic rhinitis	0.000673	0.0343	CbGeAlD
Loperamide—CALM1—exocrine gland—allergic rhinitis	0.00067	0.0341	CbGeAlD
Loperamide—CALM3—eye—allergic rhinitis	0.000408	0.0208	CbGeAlD
Loperamide—CALM3—bronchus—allergic rhinitis	0.000367	0.0187	CbGeAlD
Loperamide—CALM2—respiratory system—allergic rhinitis	0.000351	0.0178	CbGeAlD
Loperamide—CALM1—respiratory system—allergic rhinitis	0.000349	0.0178	CbGeAlD
Loperamide—CALM3—trachea—allergic rhinitis	0.00033	0.0168	CbGeAlD
Loperamide—CALM2—eye—allergic rhinitis	0.00032	0.0163	CbGeAlD
Loperamide—CALM1—eye—allergic rhinitis	0.000319	0.0162	CbGeAlD
Loperamide—CALM2—epithelium—allergic rhinitis	0.000293	0.0149	CbGeAlD
Loperamide—CALM1—epithelium—allergic rhinitis	0.000292	0.0148	CbGeAlD
Loperamide—CALM2—bronchus—allergic rhinitis	0.000289	0.0147	CbGeAlD
Loperamide—CALM1—bronchus—allergic rhinitis	0.000287	0.0146	CbGeAlD
Loperamide—CALM2—skin of body—allergic rhinitis	0.000279	0.0142	CbGeAlD
Loperamide—CALM1—skin of body—allergic rhinitis	0.000277	0.0141	CbGeAlD
Loperamide—CYP2B6—respiratory system—allergic rhinitis	0.000261	0.0133	CbGeAlD
Loperamide—CALM2—trachea—allergic rhinitis	0.000259	0.0132	CbGeAlD
Loperamide—CALM1—trachea—allergic rhinitis	0.000258	0.0131	CbGeAlD
Loperamide—CALM3—lung—allergic rhinitis	0.000237	0.0121	CbGeAlD
Loperamide—CYP2B6—bronchus—allergic rhinitis	0.000214	0.0109	CbGeAlD
Loperamide—CYP2B6—skin of body—allergic rhinitis	0.000207	0.0105	CbGeAlD
Loperamide—CALM2—lung—allergic rhinitis	0.000186	0.00948	CbGeAlD
Loperamide—CALM1—lung—allergic rhinitis	0.000185	0.00943	CbGeAlD
Loperamide—Vomiting—Cyproheptadine—allergic rhinitis	0.000178	0.00393	CcSEcCtD
Loperamide—Loss of consciousness—Cetirizine—allergic rhinitis	0.000178	0.00393	CcSEcCtD
Loperamide—Rash—Cyproheptadine—allergic rhinitis	0.000176	0.0039	CcSEcCtD
Loperamide—Dermatitis—Cyproheptadine—allergic rhinitis	0.000176	0.0039	CcSEcCtD
Loperamide—Immune system disorder—Montelukast—allergic rhinitis	0.000176	0.00389	CcSEcCtD
Loperamide—Headache—Cyproheptadine—allergic rhinitis	0.000175	0.00388	CcSEcCtD
Loperamide—Anaphylactic shock—Loratadine—allergic rhinitis	0.000175	0.00388	CcSEcCtD
Loperamide—Loss of consciousness—Flunisolide—allergic rhinitis	0.000175	0.00386	CcSEcCtD
Loperamide—Vomiting—Desloratadine—allergic rhinitis	0.000173	0.00382	CcSEcCtD
Loperamide—Nervous system disorder—Loratadine—allergic rhinitis	0.000172	0.0038	CcSEcCtD
Loperamide—Rash—Desloratadine—allergic rhinitis	0.000172	0.00379	CcSEcCtD
Loperamide—Dermatitis—Desloratadine—allergic rhinitis	0.000171	0.00379	CcSEcCtD
Loperamide—Hypersensitivity—Olopatadine—allergic rhinitis	0.000171	0.00379	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Cetirizine—allergic rhinitis	0.000171	0.00378	CcSEcCtD
Loperamide—Headache—Desloratadine—allergic rhinitis	0.00017	0.00377	CcSEcCtD
Loperamide—Skin disorder—Loratadine—allergic rhinitis	0.00017	0.00376	CcSEcCtD
Loperamide—Discomfort—Cetirizine—allergic rhinitis	0.00017	0.00376	CcSEcCtD
Loperamide—Dry mouth—Cetirizine—allergic rhinitis	0.000168	0.00372	CcSEcCtD
Loperamide—Discomfort—Flunisolide—allergic rhinitis	0.000167	0.0037	CcSEcCtD
Loperamide—Asthenia—Olopatadine—allergic rhinitis	0.000167	0.00369	CcSEcCtD
Loperamide—Nausea—Cyproheptadine—allergic rhinitis	0.000166	0.00367	CcSEcCtD
Loperamide—Anaphylactic shock—Cetirizine—allergic rhinitis	0.000165	0.00365	CcSEcCtD
Loperamide—Pruritus—Olopatadine—allergic rhinitis	0.000165	0.00364	CcSEcCtD
Loperamide—Asthenia—Dimenhydrinate—allergic rhinitis	0.000163	0.00361	CcSEcCtD
Loperamide—Asthenia—Diphenhydramine—allergic rhinitis	0.000163	0.00361	CcSEcCtD
Loperamide—Dermatitis bullous—Prednisolone—allergic rhinitis	0.000163	0.0036	CcSEcCtD
Loperamide—Nervous system disorder—Cetirizine—allergic rhinitis	0.000162	0.00358	CcSEcCtD
Loperamide—Nausea—Desloratadine—allergic rhinitis	0.000162	0.00357	CcSEcCtD
Loperamide—Anaphylactoid reaction—Prednisolone—allergic rhinitis	0.000161	0.00355	CcSEcCtD
Loperamide—Skin disorder—Cetirizine—allergic rhinitis	0.00016	0.00354	CcSEcCtD
Loperamide—Diarrhoea—Olopatadine—allergic rhinitis	0.000159	0.00352	CcSEcCtD
Loperamide—Anaphylactoid reaction—Hydrocortisone—allergic rhinitis	0.000157	0.00347	CcSEcCtD
Loperamide—Somnolence—Loratadine—allergic rhinitis	0.000156	0.00345	CcSEcCtD
Loperamide—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.000156	0.00344	CcSEcCtD
Loperamide—Diarrhoea—Diphenhydramine—allergic rhinitis	0.000156	0.00344	CcSEcCtD
Loperamide—Angioedema—Montelukast—allergic rhinitis	0.000155	0.00342	CcSEcCtD
Loperamide—Dyspepsia—Loratadine—allergic rhinitis	0.000154	0.00341	CcSEcCtD
Loperamide—Dizziness—Olopatadine—allergic rhinitis	0.000154	0.0034	CcSEcCtD
Loperamide—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.000151	0.00335	CcSEcCtD
Loperamide—Fatigue—Loratadine—allergic rhinitis	0.000151	0.00334	CcSEcCtD
Loperamide—Dizziness—Dimenhydrinate—allergic rhinitis	0.00015	0.00333	CcSEcCtD
Loperamide—Dizziness—Diphenhydramine—allergic rhinitis	0.00015	0.00333	CcSEcCtD
Loperamide—Constipation—Loratadine—allergic rhinitis	0.00015	0.00331	CcSEcCtD
Loperamide—Dermatitis bullous—Triamcinolone—allergic rhinitis	0.00015	0.00331	CcSEcCtD
Loperamide—Vomiting—Olopatadine—allergic rhinitis	0.000148	0.00327	CcSEcCtD
Loperamide—Anaphylactoid reaction—Triamcinolone—allergic rhinitis	0.000148	0.00327	CcSEcCtD
Loperamide—Anaphylactoid reaction—Methylprednisolone—allergic rhinitis	0.000147	0.00326	CcSEcCtD
Loperamide—Rash—Olopatadine—allergic rhinitis	0.000147	0.00324	CcSEcCtD
Loperamide—Somnolence—Cetirizine—allergic rhinitis	0.000147	0.00324	CcSEcCtD
Loperamide—Dermatitis—Olopatadine—allergic rhinitis	0.000146	0.00324	CcSEcCtD
Loperamide—Headache—Olopatadine—allergic rhinitis	0.000146	0.00322	CcSEcCtD
Loperamide—Dyspepsia—Cetirizine—allergic rhinitis	0.000145	0.00321	CcSEcCtD
Loperamide—Vomiting—Dimenhydrinate—allergic rhinitis	0.000145	0.0032	CcSEcCtD
Loperamide—Vomiting—Diphenhydramine—allergic rhinitis	0.000145	0.0032	CcSEcCtD
Loperamide—Rash—Dimenhydrinate—allergic rhinitis	0.000143	0.00317	CcSEcCtD
Loperamide—Rash—Diphenhydramine—allergic rhinitis	0.000143	0.00317	CcSEcCtD
Loperamide—Dermatitis—Diphenhydramine—allergic rhinitis	0.000143	0.00317	CcSEcCtD
Loperamide—Dermatitis—Dimenhydrinate—allergic rhinitis	0.000143	0.00317	CcSEcCtD
Loperamide—Gastrointestinal pain—Loratadine—allergic rhinitis	0.000143	0.00317	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.000143	0.00317	CcSEcCtD
Loperamide—Dyspepsia—Flunisolide—allergic rhinitis	0.000143	0.00316	CcSEcCtD
Loperamide—Headache—Dimenhydrinate—allergic rhinitis	0.000143	0.00315	CcSEcCtD
Loperamide—Headache—Diphenhydramine—allergic rhinitis	0.000143	0.00315	CcSEcCtD
Loperamide—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000142	0.00315	CcSEcCtD
Loperamide—Fatigue—Cetirizine—allergic rhinitis	0.000142	0.00314	CcSEcCtD
Loperamide—Constipation—Cetirizine—allergic rhinitis	0.000141	0.00312	CcSEcCtD
Loperamide—Fatigue—Flunisolide—allergic rhinitis	0.00014	0.00309	CcSEcCtD
Loperamide—ABCB1—respiratory system—allergic rhinitis	0.000139	0.00709	CbGeAlD
Loperamide—Abdominal pain upper—Hydrocortisone—allergic rhinitis	0.000139	0.00307	CcSEcCtD
Loperamide—Constipation—Flunisolide—allergic rhinitis	0.000139	0.00307	CcSEcCtD
Loperamide—Abdominal pain—Loratadine—allergic rhinitis	0.000139	0.00306	CcSEcCtD
Loperamide—CYP2B6—lung—allergic rhinitis	0.000138	0.00704	CbGeAlD
Loperamide—Anaphylactic shock—Montelukast—allergic rhinitis	0.000138	0.00306	CcSEcCtD
Loperamide—Nausea—Olopatadine—allergic rhinitis	0.000138	0.00305	CcSEcCtD
Loperamide—Dermatitis bullous—Dexamethasone—allergic rhinitis	0.000136	0.003	CcSEcCtD
Loperamide—Dermatitis bullous—Betamethasone—allergic rhinitis	0.000136	0.003	CcSEcCtD
Loperamide—Nervous system disorder—Montelukast—allergic rhinitis	0.000136	0.003	CcSEcCtD
Loperamide—Abdominal distension—Prednisolone—allergic rhinitis	0.000135	0.00299	CcSEcCtD
Loperamide—Nausea—Diphenhydramine—allergic rhinitis	0.000135	0.00299	CcSEcCtD
Loperamide—Nausea—Dimenhydrinate—allergic rhinitis	0.000135	0.00299	CcSEcCtD
Loperamide—Gastrointestinal pain—Cetirizine—allergic rhinitis	0.000135	0.00298	CcSEcCtD
Loperamide—Skin disorder—Montelukast—allergic rhinitis	0.000134	0.00297	CcSEcCtD
Loperamide—Anaphylactoid reaction—Dexamethasone—allergic rhinitis	0.000134	0.00297	CcSEcCtD
Loperamide—Anaphylactoid reaction—Betamethasone—allergic rhinitis	0.000134	0.00297	CcSEcCtD
Loperamide—Gastrointestinal pain—Flunisolide—allergic rhinitis	0.000133	0.00293	CcSEcCtD
Loperamide—Abdominal distension—Hydrocortisone—allergic rhinitis	0.000132	0.00292	CcSEcCtD
Loperamide—Urticaria—Cetirizine—allergic rhinitis	0.000131	0.0029	CcSEcCtD
Loperamide—Abdominal pain—Cetirizine—allergic rhinitis	0.00013	0.00288	CcSEcCtD
Loperamide—Urticaria—Flunisolide—allergic rhinitis	0.000129	0.00285	CcSEcCtD
Loperamide—Abdominal pain—Flunisolide—allergic rhinitis	0.000128	0.00283	CcSEcCtD
Loperamide—Asthenia—Loratadine—allergic rhinitis	0.000126	0.00278	CcSEcCtD
Loperamide—Abdominal distension—Triamcinolone—allergic rhinitis	0.000124	0.00275	CcSEcCtD
Loperamide—Abdominal distension—Methylprednisolone—allergic rhinitis	0.000124	0.00275	CcSEcCtD
Loperamide—Somnolence—Montelukast—allergic rhinitis	0.000123	0.00272	CcSEcCtD
Loperamide—Dyspepsia—Montelukast—allergic rhinitis	0.000122	0.00269	CcSEcCtD
Loperamide—Hypersensitivity—Cetirizine—allergic rhinitis	0.000122	0.00269	CcSEcCtD
Loperamide—Diarrhoea—Loratadine—allergic rhinitis	0.00012	0.00265	CcSEcCtD
Loperamide—Hypersensitivity—Flunisolide—allergic rhinitis	0.000119	0.00264	CcSEcCtD
Loperamide—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000119	0.00264	CcSEcCtD
Loperamide—Fatigue—Montelukast—allergic rhinitis	0.000119	0.00264	CcSEcCtD
Loperamide—Asthenia—Cetirizine—allergic rhinitis	0.000118	0.00262	CcSEcCtD
Loperamide—Pruritus—Cetirizine—allergic rhinitis	0.000117	0.00258	CcSEcCtD
Loperamide—ABCB1—epithelium—allergic rhinitis	0.000116	0.00593	CbGeAlD
Loperamide—Asthenia—Flunisolide—allergic rhinitis	0.000116	0.00257	CcSEcCtD
Loperamide—Dizziness—Loratadine—allergic rhinitis	0.000116	0.00256	CcSEcCtD
Loperamide—Pruritus—Flunisolide—allergic rhinitis	0.000115	0.00254	CcSEcCtD
Loperamide—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000113	0.0025	CcSEcCtD
Loperamide—Diarrhoea—Cetirizine—allergic rhinitis	0.000113	0.00249	CcSEcCtD
Loperamide—Vomiting—Loratadine—allergic rhinitis	0.000111	0.00246	CcSEcCtD
Loperamide—Diarrhoea—Flunisolide—allergic rhinitis	0.000111	0.00245	CcSEcCtD
Loperamide—Rash—Loratadine—allergic rhinitis	0.000111	0.00244	CcSEcCtD
Loperamide—Dermatitis—Loratadine—allergic rhinitis	0.00011	0.00244	CcSEcCtD
Loperamide—Urticaria—Montelukast—allergic rhinitis	0.00011	0.00243	CcSEcCtD
Loperamide—Headache—Loratadine—allergic rhinitis	0.00011	0.00243	CcSEcCtD
Loperamide—Abdominal pain—Montelukast—allergic rhinitis	0.000109	0.00242	CcSEcCtD
Loperamide—Dizziness—Cetirizine—allergic rhinitis	0.000109	0.00241	CcSEcCtD
Loperamide—Dizziness—Flunisolide—allergic rhinitis	0.000107	0.00237	CcSEcCtD
Loperamide—Vomiting—Cetirizine—allergic rhinitis	0.000105	0.00232	CcSEcCtD
Loperamide—Nausea—Loratadine—allergic rhinitis	0.000104	0.0023	CcSEcCtD
Loperamide—Rash—Cetirizine—allergic rhinitis	0.000104	0.0023	CcSEcCtD
Loperamide—Dermatitis—Cetirizine—allergic rhinitis	0.000104	0.0023	CcSEcCtD
Loperamide—Headache—Cetirizine—allergic rhinitis	0.000103	0.00228	CcSEcCtD
Loperamide—Vomiting—Flunisolide—allergic rhinitis	0.000103	0.00228	CcSEcCtD
Loperamide—ABCB1—trachea—allergic rhinitis	0.000103	0.00524	CbGeAlD
Loperamide—Rash—Flunisolide—allergic rhinitis	0.000102	0.00226	CcSEcCtD
Loperamide—Dermatitis—Flunisolide—allergic rhinitis	0.000102	0.00226	CcSEcCtD
Loperamide—Hypersensitivity—Montelukast—allergic rhinitis	0.000102	0.00225	CcSEcCtD
Loperamide—Headache—Flunisolide—allergic rhinitis	0.000102	0.00225	CcSEcCtD
Loperamide—Asthenia—Montelukast—allergic rhinitis	9.92e-05	0.00219	CcSEcCtD
Loperamide—Nausea—Cetirizine—allergic rhinitis	9.8e-05	0.00217	CcSEcCtD
Loperamide—Pruritus—Montelukast—allergic rhinitis	9.78e-05	0.00216	CcSEcCtD
Loperamide—Nausea—Flunisolide—allergic rhinitis	9.63e-05	0.00213	CcSEcCtD
Loperamide—Immune system disorder—Hydrocortisone—allergic rhinitis	9.49e-05	0.0021	CcSEcCtD
Loperamide—Diarrhoea—Montelukast—allergic rhinitis	9.46e-05	0.00209	CcSEcCtD
Loperamide—Dizziness—Montelukast—allergic rhinitis	9.15e-05	0.00202	CcSEcCtD
Loperamide—Immune system disorder—Methylprednisolone—allergic rhinitis	8.92e-05	0.00197	CcSEcCtD
Loperamide—Vomiting—Montelukast—allergic rhinitis	8.79e-05	0.00194	CcSEcCtD
Loperamide—Rash—Montelukast—allergic rhinitis	8.72e-05	0.00193	CcSEcCtD
Loperamide—Dermatitis—Montelukast—allergic rhinitis	8.71e-05	0.00193	CcSEcCtD
Loperamide—Headache—Montelukast—allergic rhinitis	8.66e-05	0.00192	CcSEcCtD
Loperamide—Angioedema—Prednisolone—allergic rhinitis	8.56e-05	0.00189	CcSEcCtD
Loperamide—Angioedema—Hydrocortisone—allergic rhinitis	8.36e-05	0.00185	CcSEcCtD
Loperamide—Loss of consciousness—Prednisolone—allergic rhinitis	8.24e-05	0.00182	CcSEcCtD
Loperamide—Nausea—Montelukast—allergic rhinitis	8.21e-05	0.00182	CcSEcCtD
Loperamide—Loss of consciousness—Hydrocortisone—allergic rhinitis	8.04e-05	0.00178	CcSEcCtD
Loperamide—Discomfort—Prednisolone—allergic rhinitis	7.88e-05	0.00174	CcSEcCtD
Loperamide—Angioedema—Triamcinolone—allergic rhinitis	7.87e-05	0.00174	CcSEcCtD
Loperamide—Angioedema—Methylprednisolone—allergic rhinitis	7.86e-05	0.00174	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	7.74e-05	0.00171	CcSEcCtD
Loperamide—Discomfort—Hydrocortisone—allergic rhinitis	7.7e-05	0.0017	CcSEcCtD
Loperamide—Anaphylactic shock—Prednisolone—allergic rhinitis	7.65e-05	0.00169	CcSEcCtD
Loperamide—Loss of consciousness—Triamcinolone—allergic rhinitis	7.57e-05	0.00167	CcSEcCtD
Loperamide—Loss of consciousness—Methylprednisolone—allergic rhinitis	7.56e-05	0.00167	CcSEcCtD
Loperamide—OPRD1—GPCR ligand binding—PTGDR2—allergic rhinitis	7.52e-05	0.00522	CbGpPWpGaD
Loperamide—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	7.48e-05	0.0052	CbGpPWpGaD
Loperamide—Anaphylactic shock—Hydrocortisone—allergic rhinitis	7.47e-05	0.00165	CcSEcCtD
Loperamide—ABCB1—lung—allergic rhinitis	7.4e-05	0.00377	CbGeAlD
Loperamide—POMC—Signaling by GPCR—CCL11—allergic rhinitis	7.37e-05	0.00512	CbGpPWpGaD
Loperamide—Nervous system disorder—Hydrocortisone—allergic rhinitis	7.32e-05	0.00162	CcSEcCtD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	7.32e-05	0.00508	CbGpPWpGaD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	7.27e-05	0.00161	CcSEcCtD
Loperamide—Skin disorder—Hydrocortisone—allergic rhinitis	7.25e-05	0.0016	CcSEcCtD
Loperamide—Discomfort—Triamcinolone—allergic rhinitis	7.25e-05	0.0016	CcSEcCtD
Loperamide—Discomfort—Methylprednisolone—allergic rhinitis	7.23e-05	0.0016	CcSEcCtD
Loperamide—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	7.22e-05	0.00501	CbGpPWpGaD
Loperamide—Dry mouth—Triamcinolone—allergic rhinitis	7.17e-05	0.00159	CcSEcCtD
Loperamide—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	7.16e-05	0.00497	CbGpPWpGaD
Loperamide—Angioedema—Betamethasone—allergic rhinitis	7.14e-05	0.00158	CcSEcCtD
Loperamide—Angioedema—Dexamethasone—allergic rhinitis	7.14e-05	0.00158	CcSEcCtD
Loperamide—OPRK1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	7.11e-05	0.00493	CbGpPWpGaD
Loperamide—Anaphylactic shock—Triamcinolone—allergic rhinitis	7.03e-05	0.00155	CcSEcCtD
Loperamide—Anaphylactic shock—Methylprednisolone—allergic rhinitis	7.02e-05	0.00155	CcSEcCtD
Loperamide—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	6.92e-05	0.0048	CbGpPWpGaD
Loperamide—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	6.92e-05	0.0048	CbGpPWpGaD
Loperamide—Nervous system disorder—Methylprednisolone—allergic rhinitis	6.88e-05	0.00152	CcSEcCtD
Loperamide—Loss of consciousness—Betamethasone—allergic rhinitis	6.87e-05	0.00152	CcSEcCtD
Loperamide—Loss of consciousness—Dexamethasone—allergic rhinitis	6.87e-05	0.00152	CcSEcCtD
Loperamide—Skin disorder—Methylprednisolone—allergic rhinitis	6.82e-05	0.00151	CcSEcCtD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	6.8e-05	0.00472	CbGpPWpGaD
Loperamide—OPRM1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	6.7e-05	0.00465	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—PTGDR2—allergic rhinitis	6.59e-05	0.00458	CbGpPWpGaD
Loperamide—Discomfort—Dexamethasone—allergic rhinitis	6.58e-05	0.00145	CcSEcCtD
Loperamide—Discomfort—Betamethasone—allergic rhinitis	6.58e-05	0.00145	CcSEcCtD
Loperamide—Dyspepsia—Hydrocortisone—allergic rhinitis	6.57e-05	0.00145	CcSEcCtD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	6.56e-05	0.00456	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	6.56e-05	0.00455	CbGpPWpGaD
Loperamide—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	6.45e-05	0.00143	CcSEcCtD
Loperamide—Fatigue—Hydrocortisone—allergic rhinitis	6.44e-05	0.00142	CcSEcCtD
Loperamide—Anaphylactic shock—Betamethasone—allergic rhinitis	6.38e-05	0.00141	CcSEcCtD
Loperamide—Anaphylactic shock—Dexamethasone—allergic rhinitis	6.38e-05	0.00141	CcSEcCtD
Loperamide—Nervous system disorder—Betamethasone—allergic rhinitis	6.26e-05	0.00138	CcSEcCtD
Loperamide—Nervous system disorder—Dexamethasone—allergic rhinitis	6.26e-05	0.00138	CcSEcCtD
Loperamide—Dyspepsia—Triamcinolone—allergic rhinitis	6.19e-05	0.00137	CcSEcCtD
Loperamide—ABCB1—Allograft Rejection—IL13—allergic rhinitis	6.18e-05	0.00429	CbGpPWpGaD
Loperamide—Dyspepsia—Methylprednisolone—allergic rhinitis	6.18e-05	0.00137	CcSEcCtD
Loperamide—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	6.11e-05	0.00135	CcSEcCtD
Loperamide—Urticaria—Prednisolone—allergic rhinitis	6.07e-05	0.00134	CcSEcCtD
Loperamide—Fatigue—Triamcinolone—allergic rhinitis	6.06e-05	0.00134	CcSEcCtD
Loperamide—Fatigue—Methylprednisolone—allergic rhinitis	6.05e-05	0.00134	CcSEcCtD
Loperamide—OPRM1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	6.01e-05	0.00417	CbGpPWpGaD
Loperamide—Urticaria—Hydrocortisone—allergic rhinitis	5.93e-05	0.00131	CcSEcCtD
Loperamide—Abdominal pain—Hydrocortisone—allergic rhinitis	5.9e-05	0.00131	CcSEcCtD
Loperamide—OPRD1—GPCR ligand binding—CYSLTR1—allergic rhinitis	5.9e-05	0.0041	CbGpPWpGaD
Loperamide—POMC—GPCR downstream signaling—TAC1—allergic rhinitis	5.9e-05	0.00409	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—PTGDR2—allergic rhinitis	5.75e-05	0.00399	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	5.74e-05	0.00399	CbGpPWpGaD
Loperamide—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	5.74e-05	0.00127	CcSEcCtD
Loperamide—OPRD1—GPCR ligand binding—CCL11—allergic rhinitis	5.7e-05	0.00396	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	5.69e-05	0.00395	CbGpPWpGaD
Loperamide—Hypersensitivity—Prednisolone—allergic rhinitis	5.63e-05	0.00125	CcSEcCtD
Loperamide—Dyspepsia—Betamethasone—allergic rhinitis	5.62e-05	0.00124	CcSEcCtD
Loperamide—Dyspepsia—Dexamethasone—allergic rhinitis	5.62e-05	0.00124	CcSEcCtD
Loperamide—Urticaria—Triamcinolone—allergic rhinitis	5.59e-05	0.00124	CcSEcCtD
Loperamide—Urticaria—Methylprednisolone—allergic rhinitis	5.57e-05	0.00123	CcSEcCtD
Loperamide—OPRM1—GPCR ligand binding—PTGDR2—allergic rhinitis	5.57e-05	0.00387	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	5.55e-05	0.00385	CbGpPWpGaD
Loperamide—Abdominal pain—Methylprednisolone—allergic rhinitis	5.55e-05	0.00123	CcSEcCtD
Loperamide—Gastrointestinal disorder—Betamethasone—allergic rhinitis	5.51e-05	0.00122	CcSEcCtD
Loperamide—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	5.51e-05	0.00122	CcSEcCtD
Loperamide—Hypersensitivity—Hydrocortisone—allergic rhinitis	5.5e-05	0.00122	CcSEcCtD
Loperamide—Fatigue—Betamethasone—allergic rhinitis	5.5e-05	0.00122	CcSEcCtD
Loperamide—Fatigue—Dexamethasone—allergic rhinitis	5.5e-05	0.00122	CcSEcCtD
Loperamide—POMC—GPCR downstream signaling—IL5—allergic rhinitis	5.48e-05	0.00381	CbGpPWpGaD
Loperamide—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	5.44e-05	0.00377	CbGpPWpGaD
Loperamide—CALM1—Melatonin metabolism and effects—NFKB1—allergic rhinitis	5.38e-05	0.00374	CbGpPWpGaD
Loperamide—CALM2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	5.38e-05	0.00374	CbGpPWpGaD
Loperamide—CALM1—T-Cell Receptor and Co-stimulatory Signaling—NFKB1—allergic rhinitis	5.38e-05	0.00374	CbGpPWpGaD
Loperamide—CALM2—T-Cell Receptor and Co-stimulatory Signaling—NFKB1—allergic rhinitis	5.38e-05	0.00374	CbGpPWpGaD
Loperamide—Asthenia—Hydrocortisone—allergic rhinitis	5.36e-05	0.00118	CcSEcCtD
Loperamide—POMC—Signaling by GPCR—TAC1—allergic rhinitis	5.36e-05	0.00372	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—IL5—allergic rhinitis	5.29e-05	0.00367	CbGpPWpGaD
Loperamide—Pruritus—Hydrocortisone—allergic rhinitis	5.28e-05	0.00117	CcSEcCtD
Loperamide—Gastrointestinal pain—Dexamethasone—allergic rhinitis	5.22e-05	0.00115	CcSEcCtD
Loperamide—Gastrointestinal pain—Betamethasone—allergic rhinitis	5.22e-05	0.00115	CcSEcCtD
Loperamide—Hypersensitivity—Triamcinolone—allergic rhinitis	5.18e-05	0.00115	CcSEcCtD
Loperamide—OPRK1—GPCR ligand binding—CYSLTR1—allergic rhinitis	5.17e-05	0.00359	CbGpPWpGaD
Loperamide—Hypersensitivity—Methylprednisolone—allergic rhinitis	5.17e-05	0.00114	CcSEcCtD
Loperamide—Diarrhoea—Hydrocortisone—allergic rhinitis	5.11e-05	0.00113	CcSEcCtD
Loperamide—Urticaria—Dexamethasone—allergic rhinitis	5.07e-05	0.00112	CcSEcCtD
Loperamide—Urticaria—Betamethasone—allergic rhinitis	5.07e-05	0.00112	CcSEcCtD
Loperamide—Dizziness—Prednisolone—allergic rhinitis	5.06e-05	0.00112	CcSEcCtD
Loperamide—Asthenia—Triamcinolone—allergic rhinitis	5.05e-05	0.00112	CcSEcCtD
Loperamide—Abdominal pain—Betamethasone—allergic rhinitis	5.04e-05	0.00112	CcSEcCtD
Loperamide—Abdominal pain—Dexamethasone—allergic rhinitis	5.04e-05	0.00112	CcSEcCtD
Loperamide—Asthenia—Methylprednisolone—allergic rhinitis	5.03e-05	0.00111	CcSEcCtD
Loperamide—OPRK1—GPCR ligand binding—CCL11—allergic rhinitis	5e-05	0.00347	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—IL5—allergic rhinitis	4.98e-05	0.00346	CbGpPWpGaD
Loperamide—Pruritus—Triamcinolone—allergic rhinitis	4.98e-05	0.0011	CcSEcCtD
Loperamide—Pruritus—Methylprednisolone—allergic rhinitis	4.96e-05	0.0011	CcSEcCtD
Loperamide—Dizziness—Hydrocortisone—allergic rhinitis	4.94e-05	0.00109	CcSEcCtD
Loperamide—Rash—Prednisolone—allergic rhinitis	4.82e-05	0.00107	CcSEcCtD
Loperamide—Dermatitis—Prednisolone—allergic rhinitis	4.82e-05	0.00106	CcSEcCtD
Loperamide—Diarrhoea—Methylprednisolone—allergic rhinitis	4.8e-05	0.00106	CcSEcCtD
Loperamide—Headache—Prednisolone—allergic rhinitis	4.79e-05	0.00106	CcSEcCtD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	4.77e-05	0.00331	CbGpPWpGaD
Loperamide—Vomiting—Hydrocortisone—allergic rhinitis	4.75e-05	0.00105	CcSEcCtD
Loperamide—Rash—Hydrocortisone—allergic rhinitis	4.71e-05	0.00104	CcSEcCtD
Loperamide—Dermatitis—Hydrocortisone—allergic rhinitis	4.7e-05	0.00104	CcSEcCtD
Loperamide—Headache—Hydrocortisone—allergic rhinitis	4.68e-05	0.00103	CcSEcCtD
Loperamide—Dizziness—Triamcinolone—allergic rhinitis	4.65e-05	0.00103	CcSEcCtD
Loperamide—Dizziness—Methylprednisolone—allergic rhinitis	4.64e-05	0.00103	CcSEcCtD
Loperamide—CALM3—IL2 signaling events mediated by PI3K—NFKB1—allergic rhinitis	4.58e-05	0.00318	CbGpPWpGaD
Loperamide—Asthenia—Dexamethasone—allergic rhinitis	4.58e-05	0.00101	CcSEcCtD
Loperamide—Asthenia—Betamethasone—allergic rhinitis	4.58e-05	0.00101	CcSEcCtD
Loperamide—Nausea—Prednisolone—allergic rhinitis	4.54e-05	0.001	CcSEcCtD
Loperamide—Pruritus—Dexamethasone—allergic rhinitis	4.51e-05	0.000998	CcSEcCtD
Loperamide—Pruritus—Betamethasone—allergic rhinitis	4.51e-05	0.000998	CcSEcCtD
Loperamide—POMC—Signaling Pathways—CYSLTR1—allergic rhinitis	4.51e-05	0.00313	CbGpPWpGaD
Loperamide—Vomiting—Triamcinolone—allergic rhinitis	4.47e-05	0.000989	CcSEcCtD
Loperamide—Vomiting—Methylprednisolone—allergic rhinitis	4.46e-05	0.000986	CcSEcCtD
Loperamide—Nausea—Hydrocortisone—allergic rhinitis	4.44e-05	0.000981	CcSEcCtD
Loperamide—Rash—Triamcinolone—allergic rhinitis	4.43e-05	0.00098	CcSEcCtD
Loperamide—CALM1—IL2 signaling events mediated by PI3K—NFKB1—allergic rhinitis	4.43e-05	0.00307	CbGpPWpGaD
Loperamide—CALM2—IL2 signaling events mediated by PI3K—NFKB1—allergic rhinitis	4.43e-05	0.00307	CbGpPWpGaD
Loperamide—Dermatitis—Triamcinolone—allergic rhinitis	4.43e-05	0.000979	CcSEcCtD
Loperamide—Rash—Methylprednisolone—allergic rhinitis	4.42e-05	0.000978	CcSEcCtD
Loperamide—Dermatitis—Methylprednisolone—allergic rhinitis	4.42e-05	0.000977	CcSEcCtD
Loperamide—Headache—Triamcinolone—allergic rhinitis	4.41e-05	0.000974	CcSEcCtD
Loperamide—Headache—Methylprednisolone—allergic rhinitis	4.4e-05	0.000972	CcSEcCtD
Loperamide—OPRM1—GPCR ligand binding—CYSLTR1—allergic rhinitis	4.37e-05	0.00304	CbGpPWpGaD
Loperamide—Diarrhoea—Dexamethasone—allergic rhinitis	4.37e-05	0.000965	CcSEcCtD
Loperamide—Diarrhoea—Betamethasone—allergic rhinitis	4.37e-05	0.000965	CcSEcCtD
Loperamide—POMC—Signaling Pathways—CCL11—allergic rhinitis	4.35e-05	0.00302	CbGpPWpGaD
Loperamide—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	4.3e-05	0.00298	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—PTGDR2—allergic rhinitis	4.25e-05	0.00295	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—CCL11—allergic rhinitis	4.22e-05	0.00293	CbGpPWpGaD
Loperamide—Dizziness—Betamethasone—allergic rhinitis	4.22e-05	0.000933	CcSEcCtD
Loperamide—Dizziness—Dexamethasone—allergic rhinitis	4.22e-05	0.000933	CcSEcCtD
Loperamide—OPRM1—TCR Signaling Pathway—CD4—allergic rhinitis	4.22e-05	0.00293	CbGpPWpGaD
Loperamide—Nausea—Triamcinolone—allergic rhinitis	4.18e-05	0.000923	CcSEcCtD
Loperamide—Nausea—Methylprednisolone—allergic rhinitis	4.17e-05	0.000921	CcSEcCtD
Loperamide—OPRD1—GPCR ligand binding—TAC1—allergic rhinitis	4.14e-05	0.00287	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	4.09e-05	0.00284	CbGpPWpGaD
Loperamide—Vomiting—Dexamethasone—allergic rhinitis	4.06e-05	0.000897	CcSEcCtD
Loperamide—Vomiting—Betamethasone—allergic rhinitis	4.06e-05	0.000897	CcSEcCtD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	4.03e-05	0.0028	CbGpPWpGaD
Loperamide—Rash—Betamethasone—allergic rhinitis	4.02e-05	0.000889	CcSEcCtD
Loperamide—Rash—Dexamethasone—allergic rhinitis	4.02e-05	0.000889	CcSEcCtD
Loperamide—Dermatitis—Betamethasone—allergic rhinitis	4.02e-05	0.000889	CcSEcCtD
Loperamide—Dermatitis—Dexamethasone—allergic rhinitis	4.02e-05	0.000889	CcSEcCtD
Loperamide—Headache—Betamethasone—allergic rhinitis	4e-05	0.000884	CcSEcCtD
Loperamide—Headache—Dexamethasone—allergic rhinitis	4e-05	0.000884	CcSEcCtD
Loperamide—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	3.97e-05	0.00276	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—IL10—allergic rhinitis	3.87e-05	0.00268	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—PTGDR2—allergic rhinitis	3.86e-05	0.00268	CbGpPWpGaD
Loperamide—Nausea—Betamethasone—allergic rhinitis	3.79e-05	0.000838	CcSEcCtD
Loperamide—Nausea—Dexamethasone—allergic rhinitis	3.79e-05	0.000838	CcSEcCtD
Loperamide—ABCB1—Allograft Rejection—IL4—allergic rhinitis	3.76e-05	0.00261	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.73e-05	0.00259	CbGpPWpGaD
Loperamide—OPRM1—TCR Signaling Pathway—NFKB1—allergic rhinitis	3.63e-05	0.00252	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—TAC1—allergic rhinitis	3.63e-05	0.00252	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—PTGDR2—allergic rhinitis	3.38e-05	0.00235	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.34e-05	0.00231	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—MS4A2—allergic rhinitis	3.27e-05	0.00227	CbGpPWpGaD
Loperamide—CALM1—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	3.23e-05	0.00224	CbGpPWpGaD
Loperamide—CALM2—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	3.23e-05	0.00224	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TAC1—allergic rhinitis	3.16e-05	0.0022	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—MS4A2—allergic rhinitis	3.16e-05	0.00219	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—MS4A2—allergic rhinitis	3.16e-05	0.00219	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.15e-05	0.00219	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—TAC1—allergic rhinitis	3.07e-05	0.00213	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	3.06e-05	0.00213	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.03e-05	0.0021	CbGpPWpGaD
Loperamide—OPRM1—TCR Signaling Pathway—TGFB1—allergic rhinitis	3.03e-05	0.0021	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	2.96e-05	0.00206	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	2.96e-05	0.00206	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—IL5—allergic rhinitis	2.94e-05	0.00204	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—CCL11—allergic rhinitis	2.93e-05	0.00203	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.92e-05	0.00203	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—PTGDR2—allergic rhinitis	2.86e-05	0.00199	CbGpPWpGaD
Loperamide—CALM3—BCR signaling pathway—NFKB1—allergic rhinitis	2.85e-05	0.00198	CbGpPWpGaD
Loperamide—CALM1—BCR signaling pathway—NFKB1—allergic rhinitis	2.75e-05	0.00191	CbGpPWpGaD
Loperamide—CALM2—BCR signaling pathway—NFKB1—allergic rhinitis	2.75e-05	0.00191	CbGpPWpGaD
Loperamide—CALM2—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	2.69e-05	0.00187	CbGpPWpGaD
Loperamide—CALM1—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	2.69e-05	0.00187	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.66e-05	0.00184	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—CCL11—allergic rhinitis	2.56e-05	0.00178	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.47e-05	0.00172	CbGpPWpGaD
Loperamide—CALM2—Endochondral Ossification—TGFB1—allergic rhinitis	2.38e-05	0.00165	CbGpPWpGaD
Loperamide—CALM1—Endochondral Ossification—TGFB1—allergic rhinitis	2.38e-05	0.00165	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—TAC1—allergic rhinitis	2.34e-05	0.00162	CbGpPWpGaD
Loperamide—CALM1—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	2.3e-05	0.0016	CbGpPWpGaD
Loperamide—CALM2—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	2.3e-05	0.0016	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—PTGDR2—allergic rhinitis	2.28e-05	0.00158	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.24e-05	0.00156	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—IL5—allergic rhinitis	2.18e-05	0.00151	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—CCL11—allergic rhinitis	2.17e-05	0.0015	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—TAC1—allergic rhinitis	2.13e-05	0.00148	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—SMAD3—allergic rhinitis	2.07e-05	0.00144	CbGpPWpGaD
Loperamide—CALM3—Platelet degranulation—TGFB1—allergic rhinitis	2.06e-05	0.00143	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—TAC1—allergic rhinitis	2.05e-05	0.00142	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—PTGDR2—allergic rhinitis	2e-05	0.00139	CbGpPWpGaD
Loperamide—CALM1—Platelet degranulation—TGFB1—allergic rhinitis	1.99e-05	0.00138	CbGpPWpGaD
Loperamide—CALM2—Platelet degranulation—TGFB1—allergic rhinitis	1.99e-05	0.00138	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—IL5—allergic rhinitis	1.98e-05	0.00137	CbGpPWpGaD
Loperamide—CALM3—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	1.96e-05	0.00136	CbGpPWpGaD
Loperamide—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	1.92e-05	0.00133	CbGpPWpGaD
Loperamide—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	1.92e-05	0.00133	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—IL5—allergic rhinitis	1.91e-05	0.00132	CbGpPWpGaD
Loperamide—CALM3—Immune System—MS4A2—allergic rhinitis	1.9e-05	0.00132	CbGpPWpGaD
Loperamide—CALM1—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	1.9e-05	0.00132	CbGpPWpGaD
Loperamide—CALM2—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	1.9e-05	0.00132	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—TAC1—allergic rhinitis	1.86e-05	0.00129	CbGpPWpGaD
Loperamide—CALM2—Immune System—MS4A2—allergic rhinitis	1.84e-05	0.00128	CbGpPWpGaD
Loperamide—CALM1—Immune System—MS4A2—allergic rhinitis	1.84e-05	0.00128	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CYSLTR1—allergic rhinitis	1.79e-05	0.00124	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—PTGDR2—allergic rhinitis	1.77e-05	0.00123	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—TAC1—allergic rhinitis	1.73e-05	0.0012	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL5—allergic rhinitis	1.73e-05	0.0012	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CCL11—allergic rhinitis	1.73e-05	0.0012	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—PTGDR2—allergic rhinitis	1.71e-05	0.00119	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—PTGDR2—allergic rhinitis	1.71e-05	0.00119	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HLA-G—allergic rhinitis	1.69e-05	0.00118	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—PTGDR2—allergic rhinitis	1.69e-05	0.00117	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HLA-G—allergic rhinitis	1.64e-05	0.00114	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HLA-G—allergic rhinitis	1.64e-05	0.00114	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—IL5—allergic rhinitis	1.61e-05	0.00112	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—IL5—allergic rhinitis	1.58e-05	0.0011	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	1.58e-05	0.00109	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—TAC1—allergic rhinitis	1.57e-05	0.00109	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CYSLTR1—allergic rhinitis	1.57e-05	0.00109	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—IL5—allergic rhinitis	1.53e-05	0.00106	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—IL5—allergic rhinitis	1.53e-05	0.00106	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CCL11—allergic rhinitis	1.52e-05	0.00105	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL5—allergic rhinitis	1.46e-05	0.00102	CbGpPWpGaD
Loperamide—CALM3—Myometrial Relaxation and Contraction Pathways—NFKB1—allergic rhinitis	1.46e-05	0.00101	CbGpPWpGaD
Loperamide—CALM2—Myometrial Relaxation and Contraction Pathways—NFKB1—allergic rhinitis	1.41e-05	0.000978	CbGpPWpGaD
Loperamide—CALM1—Myometrial Relaxation and Contraction Pathways—NFKB1—allergic rhinitis	1.41e-05	0.000978	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.39e-05	0.000964	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.34e-05	0.000933	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.34e-05	0.000933	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—CCL11—allergic rhinitis	1.34e-05	0.000931	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CYSLTR1—allergic rhinitis	1.33e-05	0.00092	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	1.31e-05	0.000909	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—CCL11—allergic rhinitis	1.3e-05	0.000901	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—CCL11—allergic rhinitis	1.3e-05	0.000901	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CCL11—allergic rhinitis	1.28e-05	0.000889	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	1.27e-05	0.000879	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	1.27e-05	0.000879	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TAC1—allergic rhinitis	1.26e-05	0.000871	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—NFKB1—allergic rhinitis	1.21e-05	0.000841	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—NFKB1—allergic rhinitis	1.17e-05	0.000814	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—NFKB1—allergic rhinitis	1.17e-05	0.000814	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL5—allergic rhinitis	1.17e-05	0.00081	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TAC1—allergic rhinitis	1.1e-05	0.000764	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HLA-DQB1—allergic rhinitis	1.06e-05	0.000734	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—NFKB1—allergic rhinitis	1.05e-05	0.00073	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PTGDR2—allergic rhinitis	1.05e-05	0.000726	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-G—allergic rhinitis	1.03e-05	0.000713	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL5—allergic rhinitis	1.02e-05	0.00071	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HLA-DQB1—allergic rhinitis	1.02e-05	0.00071	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	1.02e-05	0.00071	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PTGDR2—allergic rhinitis	1.01e-05	0.000702	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PTGDR2—allergic rhinitis	1.01e-05	0.000702	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-G—allergic rhinitis	9.94e-06	0.00069	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-G—allergic rhinitis	9.94e-06	0.00069	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—TAC1—allergic rhinitis	9.75e-06	0.000677	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—TAC1—allergic rhinitis	9.43e-06	0.000655	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—TAC1—allergic rhinitis	9.43e-06	0.000655	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	9.34e-06	0.000648	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TAC1—allergic rhinitis	9.3e-06	0.000646	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	9.13e-06	0.000634	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL5—allergic rhinitis	9.06e-06	0.000629	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—NFKB1—allergic rhinitis	8.92e-06	0.000619	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	8.83e-06	0.000613	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	8.83e-06	0.000613	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL5—allergic rhinitis	8.77e-06	0.000609	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL5—allergic rhinitis	8.77e-06	0.000609	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TGFB1—allergic rhinitis	8.77e-06	0.000608	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL5—allergic rhinitis	8.65e-06	0.0006	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—NFKB1—allergic rhinitis	8.63e-06	0.000599	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—NFKB1—allergic rhinitis	8.63e-06	0.000599	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL5—allergic rhinitis	8.28e-06	0.000575	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—SMAD3—allergic rhinitis	8.21e-06	0.00057	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CYSLTR1—allergic rhinitis	8.21e-06	0.00057	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL5—allergic rhinitis	8.01e-06	0.000556	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL5—allergic rhinitis	8.01e-06	0.000556	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CYSLTR1—allergic rhinitis	7.94e-06	0.000551	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CYSLTR1—allergic rhinitis	7.94e-06	0.000551	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCL11—allergic rhinitis	7.93e-06	0.00055	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	7.78e-06	0.00054	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—ICAM1—allergic rhinitis	7.71e-06	0.000536	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCL11—allergic rhinitis	7.67e-06	0.000532	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCL11—allergic rhinitis	7.67e-06	0.000532	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—ICAM1—allergic rhinitis	7.46e-06	0.000518	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—ICAM1—allergic rhinitis	7.46e-06	0.000518	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—SMAD3—allergic rhinitis	7.2e-06	0.0005	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-DQB1—allergic rhinitis	6.41e-06	0.000445	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-DQB1—allergic rhinitis	6.2e-06	0.000431	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-DQB1—allergic rhinitis	6.2e-06	0.000431	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SMAD3—allergic rhinitis	6.09e-06	0.000423	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CD4—allergic rhinitis	5.9e-06	0.00041	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TAC1—allergic rhinitis	5.76e-06	0.0004	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CD4—allergic rhinitis	5.71e-06	0.000396	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CD4—allergic rhinitis	5.71e-06	0.000396	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD4—allergic rhinitis	5.67e-06	0.000394	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TAC1—allergic rhinitis	5.57e-06	0.000387	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TAC1—allergic rhinitis	5.57e-06	0.000387	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD4—allergic rhinitis	5.48e-06	0.000381	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD4—allergic rhinitis	5.48e-06	0.000381	CbGpPWpGaD
Loperamide—CALM3—Disease—SMAD3—allergic rhinitis	5.38e-06	0.000374	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL5—allergic rhinitis	5.35e-06	0.000372	CbGpPWpGaD
Loperamide—CALM1—Disease—SMAD3—allergic rhinitis	5.21e-06	0.000361	CbGpPWpGaD
Loperamide—CALM2—Disease—SMAD3—allergic rhinitis	5.21e-06	0.000361	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL5—allergic rhinitis	5.18e-06	0.00036	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL5—allergic rhinitis	5.18e-06	0.00036	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—NFKB1—allergic rhinitis	5.09e-06	0.000353	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—NFKB1—allergic rhinitis	4.92e-06	0.000342	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—NFKB1—allergic rhinitis	4.92e-06	0.000342	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—NFKB1—allergic rhinitis	4.88e-06	0.000339	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—NFKB1—allergic rhinitis	4.73e-06	0.000328	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—NFKB1—allergic rhinitis	4.73e-06	0.000328	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TGFB1—allergic rhinitis	4.71e-06	0.000327	CbGpPWpGaD
Loperamide—CALM3—Immune System—ICAM1—allergic rhinitis	4.68e-06	0.000325	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TGFB1—allergic rhinitis	4.55e-06	0.000316	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TGFB1—allergic rhinitis	4.55e-06	0.000316	CbGpPWpGaD
Loperamide—CALM2—Immune System—ICAM1—allergic rhinitis	4.53e-06	0.000314	CbGpPWpGaD
Loperamide—CALM1—Immune System—ICAM1—allergic rhinitis	4.53e-06	0.000314	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NFKB1—allergic rhinitis	4.18e-06	0.00029	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SMAD3—allergic rhinitis	3.77e-06	0.000262	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NFKB1—allergic rhinitis	3.66e-06	0.000254	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SMAD3—allergic rhinitis	3.65e-06	0.000253	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SMAD3—allergic rhinitis	3.65e-06	0.000253	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TGFB1—allergic rhinitis	3.48e-06	0.000241	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD4—allergic rhinitis	3.44e-06	0.000239	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD4—allergic rhinitis	3.33e-06	0.000231	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD4—allergic rhinitis	3.33e-06	0.000231	CbGpPWpGaD
Loperamide—CALM3—Disease—CD4—allergic rhinitis	3.17e-06	0.00022	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NFKB1—allergic rhinitis	3.09e-06	0.000215	CbGpPWpGaD
Loperamide—CALM1—Disease—CD4—allergic rhinitis	3.07e-06	0.000213	CbGpPWpGaD
Loperamide—CALM2—Disease—CD4—allergic rhinitis	3.07e-06	0.000213	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TGFB1—allergic rhinitis	3.05e-06	0.000212	CbGpPWpGaD
Loperamide—CALM3—Immune System—NFKB1—allergic rhinitis	2.96e-06	0.000206	CbGpPWpGaD
Loperamide—CALM1—Immune System—NFKB1—allergic rhinitis	2.87e-06	0.000199	CbGpPWpGaD
Loperamide—CALM2—Immune System—NFKB1—allergic rhinitis	2.87e-06	0.000199	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFB1—allergic rhinitis	2.58e-06	0.000179	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—allergic rhinitis	2.28e-06	0.000158	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—allergic rhinitis	2.2e-06	0.000153	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—allergic rhinitis	2.2e-06	0.000153	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NFKB1—allergic rhinitis	1.92e-06	0.000133	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NFKB1—allergic rhinitis	1.85e-06	0.000129	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NFKB1—allergic rhinitis	1.85e-06	0.000129	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—allergic rhinitis	1.6e-06	0.000111	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—allergic rhinitis	1.54e-06	0.000107	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—allergic rhinitis	1.54e-06	0.000107	CbGpPWpGaD
